This book is the revised version of a doctoral thesis written at the Graduiertenkolleg Law and Economics at Hamburg University. It addresses the market failure with respect to R&D for medicines for tropical diseases and the lack of access to affordable medicines in poor countries. Tropical...

This publication examines how drug originator manufacturers manage to shield their products from competition. It characterizes the pharmaceutical industry in detail and analyzes actions that violate antitrust laws in the USA and/or the European Union. The publication examines, for example,...

As ‘disruption’ is currently becoming the new buzzword in boardrooms, this book advocates that the most striking opportunity for business today is making itself relevant to its stakeholders. By presenting a new route via innovative business models, a transformational corporate approach to...

This book explores technological innovation in family firms, seeking to reconstruct the links between the heterogeneous dimensions of family businesses and their innovative behaviour. Building on and examining the traditional view of family firms as conservative, this book contributes to...

This study analyzes the impact of the revision of the Indian Patent Act (2005) on the Indian pharmaceutical industry, which has been achieving healthy growth over the past 30 to 40 years or more. As of 2005, the Indian pharmaceutical industry was ranked as No. 4 in the world in terms of volume...

This book explores the unfinished India-Pakistan Trade normalisation agenda (building upon the themes covered in the book “India-Pakistan Trade: Strengthening Economic Relations” published by Springer in 2014) and discusses the steps that must be undertaken in order to move the bilateral...

This book is open access under a CC-BY license. This book is about medicines production in sub-Saharan Africa, an enquiry driven by the vast unmet health needs of the sub-continent. It is a collective endeavour by a group of editors and authors with a strong African and more broadly Southern...

This book investigates and highlights the most critical challenges the pharmaceutical industry faces in an increasingly competitive environment of inflationary R&D investments and tightening cost control pressures. The authors present three sources of pharmaceutical innovation: new management...

In India today only 35 percent of people have access to medicines. This book examines the rise of drug prices in India, and develops a new healthcare model, which if implemented, would extend access to medicines to India's entire population. Sensitivity tests show that the proposed model is...